Page results
-
This page is for patients receiving steroids for immunotherapy toxicity.
-
Researchers at UCLH and Imperial College Healthcare NHS Trust are to trial a new weight loss treatment which involves reducing blood supply to part of the stomach.
-
A new study that aims to improve the quality of MRI scans for prostate cancer screening has identified simple ways to treble the number of scans that are of optimal diagnostic quality.
-
UCLH is to host to a new collaboration researching patient safety, after being awarded £3million in funding.
-
The psychology team at UCLH are running the next 'Navigating the exam period' group on Wednesday 19 February, from 1pm - 4pm.
-
Dr Manjit Matharu's major research interests include migraine, trigeminal autonomic cephalalgias, facial pain, neurostimulation for intractable headaches, spontaneous intracranial hypotension and other headache disorders in hypermobility syndromes.
-
UCLH is delighted to announce the appointment of Dr Steve Harris as Chief Research Information Officer (CRIO).
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
NHS England has published a proposed interim specification for the new services for children and young people experiencing gender dysphoria.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
